Status:
COMPLETED
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Lead Sponsor:
University of California, Los Angeles
Conditions:
Pain, Postoperative
Analgesics, Opioid
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A blinded randomized control trial in living kidney donors. The study group will receive a liposomal bupivacaine Trans Quadratus Lumborum (TQL) block after the induction of general anesthesia. The fol...
Detailed Description
This is a blinded (patients are blinded and all the staff and the nurses who collect data are also blinded) randomized controlled trial in living kidney donors who have been approved by a multidiscipl...
Eligibility Criteria
Inclusion
- Patients undergoing laparoscopic donor nephrectomy
Exclusion
- Pregnancy
- Systemic or local infection at the potential block site.
- Allergy or hypersensitivity to the local anesthetic,
- Possible variations in surgical approach to donor nephrectomy other than what is defined in this protocol.
- Scarring or anatomic abnormality over the proposed injection site
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 24 2020
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT03294109
Start Date
January 1 2018
End Date
June 24 2020
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connie Frank Kidney Transplant Center
Los Angeles, California, United States, 90095